To each their own. My personal opinion is that this stock has huge potential with P3 completed and readout to come. aGVHD market is negligible compared to OA and my bet is that the trial result will be a company maker.
I respect your decision. Result will prove one way or another.
- Forums
- ASX - By Stock
- CYP Price Target post MSB FDA approval.
CYP
cynata therapeutics limited
Add to My Watchlist
6.25%
!
17.0¢

To each their own. My personal opinion is that this stock has...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
17.0¢ |
Change
0.010(6.25%) |
Mkt cap ! $38.41M |
Open | High | Low | Value | Volume |
16.0¢ | 17.5¢ | 16.0¢ | $45.60K | 278.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 62994 | 16.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
17.5¢ | 107450 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 62994 | 0.160 |
4 | 66451 | 0.155 |
2 | 55000 | 0.150 |
2 | 45937 | 0.140 |
1 | 25000 | 0.130 |
Price($) | Vol. | No. |
---|---|---|
0.175 | 107450 | 3 |
0.180 | 113494 | 5 |
0.185 | 35990 | 1 |
0.190 | 8868 | 1 |
0.195 | 22055 | 2 |
Last trade - 15.17pm 18/06/2025 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online